期刊
MOLECULAR AND CELLULAR BIOLOGY
卷 28, 期 24, 页码 7465-7475出版社
AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.00715-08
关键词
-
资金
- INSERM
- CNRS
- Hopital Universitaire de Strasbourg
- Association pour la Recherche sur le Cancer (ARC)
- Fondation de France
- Ligue Nationale Francaise Contre le Cancer (LNCC
- Equipe Labellisee)
- Ligue Regionale (Haut-Rhin) Contre le Cancer
- Agence Nationale de la Recherche
- Institut National du Cancer
- LNCC
- ARC
- Ministere de la Recherche et de la Technologie
- Fondation pour la Recherche Medicale
Notch activity is essential for early T-cell differentiation, but aberrant activity induces T-cell transformation. Thus, Notch target genes must be efficiently silenced in cells where Notch activity is no longer required. How these genes are repressed remains poorly understood. We report here that the Ikaros transcription factor plays a crucial role in repressing the transcriptional response to Notch signaling in T-cell development. Using the Notch target gene Hes-1 as a model, we show that Ikaros and RBP-J kappa, the transcriptional mediator of Notch signaling, compete for binding to two elements in the Hes-1 promoter in immature thymocytes. This antagonistic interaction likely occurs at the CD4(-) CD8(-) CD3(-) double-negative 4 (DN4) stage, where Ikaros levels and binding to the Hes-1 promoter increase sharply and wild-type thymocytes lose their capacity to transcribe Hes-1 upon Notch stimulation. Nonresponsiveness to Notch signaling requires Ikaros, as Ikaros-deficient DN4 and CD4(-) CD8(-) double-positive (DP) cells remain competent to express Hes-1 after Notch activation. Further, Hes-1 promoter sequences from Ikaros-deficient DP cells show reduced trimethylated H3K27, a modification associated with silent chromatin. These results indicate that Ikaros functions as a transcriptional checkpoint to repress Notch target gene expression in T cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据